These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10875933)

  • 21. N-terminal proteolytic processing of porcine chromogranin A in parathyroid tissue.
    Fasciotto BH; Cohn DV; Gorr SU
    Regul Pept; 2002 Jan; 103(1):53-8. PubMed ID: 11738248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromogranin A.
    Hendy GN; Bevan S; Mattei MG; Mouland AJ
    Clin Invest Med; 1995 Feb; 18(1):47-65. PubMed ID: 7768066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cloning of chromogranin A from rat pheochromocytoma cells.
    Parmer RJ; Koop AH; Handa MT; O'Connor DT
    Hypertension; 1989 Oct; 14(4):435-44. PubMed ID: 2793216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A.
    Stridsberg M; Eriksson B; Oberg K; Janson ET
    Regul Pept; 2004 Mar; 117(3):219-27. PubMed ID: 14749043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secretory granule biogenesis and neuropeptide sorting to the regulated secretory pathway in neuroendocrine cells.
    Loh YP; Kim T; Rodriguez YM; Cawley NX
    J Mol Neurosci; 2004; 22(1-2):63-71. PubMed ID: 14742911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A.
    Taupenot L; Harper KL; Mahapatra NR; Parmer RJ; Mahata SK; O'Connor DT
    J Cell Sci; 2002 Dec; 115(Pt 24):4827-41. PubMed ID: 12432071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary cells and pancreatic beta-cells.
    Hosaka M; Watanabe T; Sakai Y; Uchiyama Y; Takeuchi T
    Mol Biol Cell; 2002 Oct; 13(10):3388-99. PubMed ID: 12388744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion.
    Drees BM; Rouse J; Johnson J; Hamilton JW
    Endocrinology; 1991 Dec; 129(6):3381-7. PubMed ID: 1954912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245).
    Degorce F; Goumon Y; Jacquemart L; Vidaud C; Bellanger L; Pons-Anicet D; Seguin P; Metz-Boutigue MH; Aunis D
    Br J Cancer; 1999 Jan; 79(1):65-71. PubMed ID: 10408695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A proposed role for chromogranin A as a glucocorticoid-responsive autocrine inhibitor of proopiomelanocortin secretion.
    Wand GS; Takiyyuddin M; O'Connor DT; Levine MA
    Endocrinology; 1991 Mar; 128(3):1345-51. PubMed ID: 1999156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments.
    Aardal S; Helle KB; Elsayed S; Reed RK; Serck-Hanssen G
    J Neuroendocrinol; 1993 Aug; 5(4):405-12. PubMed ID: 8401564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation and O-glycosylation sites of human chromogranin A (CGA79-439) from urine of patients with carcinoid tumors.
    Gadroy P; Stridsberg M; Capon C; Michalski JC; Strub JM; Van Dorsselaer A; Aunis D; Metz-Boutigue MH
    J Biol Chem; 1998 Dec; 273(51):34087-97. PubMed ID: 9852066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release.
    Jiang Q; Taupenot L; Mahata SK; Mahata M; O'Connor DT; Miles LA; Parmer RJ
    J Biol Chem; 2001 Jul; 276(27):25022-9. PubMed ID: 11342539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromogranin A from bovine adrenal medulla: molecular characterization of glycosylations, phosphorylations, and sequence heterogeneities by mass spectrometry.
    Bauer SH; Zhang XY; Van Dongen W; Claeys M; Przybylski M
    Anal Biochem; 1999 Oct; 274(1):69-80. PubMed ID: 10527498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inositol 1,4,5-trisphosphate receptor/Ca2+ channel modulatory role of chromogranin A, a Ca2+ storage protein of secretory granules.
    Yoo SH; Jeon CJ
    J Biol Chem; 2000 May; 275(20):15067-73. PubMed ID: 10748130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A.
    Angeletti RH; Aardal S; Serck-Hanssen G; Gee P; Helle KB
    Acta Physiol Scand; 1994 Sep; 152(1):11-9. PubMed ID: 7810329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2.
    Arden SD; Rutherford NG; Guest PC; Curry WJ; Bailyes EM; Johnston CF; Hutton JC
    Biochem J; 1994 Mar; 298 Pt 3(Pt 3):521-8. PubMed ID: 8141763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic regions of human chromogranin A and their topographic relationships with structural/functional domains.
    Corti A; Longhi R; Gasparri A; Chen F; Pelagi M; Siccardi AG
    Eur J Biochem; 1996 Jan; 235(1-2):275-80. PubMed ID: 8631342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PC12 cells show immunoreactivity to a number of proteins and peptides, including vasostatin.
    Cunningham RT; Pogue KM; Curry WJ; Johnston CF; Buchanan KD
    Peptides; 1996; 17(8):1297-301. PubMed ID: 8971922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretion from chromaffin cells is controlled by chromogranin A-derived peptides.
    Simon JP; Bader MF; Aunis D
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1712-6. PubMed ID: 3422758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.